Downstream Bioprocessing Market and Downstream Processing in Biopharmaceuticals 2017 Market Dynamics, Segments and Growth Analysis to 2021

1
MarketsandMarkets Presents
Downstream Bioprocessing Market and Downstream
Processing in Biopharmaceuticals 2017 Market
Dynamics, Segments and Growth Analysis to 2021
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
2
The report " Downstream Bioprocessing Market and
Downstream Processing in Biopharmaceuticals by
Technique (Separation, Concentration,
Purification), Product (Chromatography Column
Resin, Filter, Single use), Application (Mab
Production), End User (Contract Manufacturing
Organization) - Global Forecast to 2021, The
Downstream Bioprocessing Market and Downstream
Processing in Biopharmaceuticals is poised to
reach USD 22.03 Billion by 2021 from USD 10.32
Billion in 2016, at a CAGR of 16.4 from 2016 to
2021.. Browse 60 market data tables 40 figures
139 pages And in-depth TOC on Downstream
Bioprocessing Market and Downstream Processing in
Biopharmaceuticals Download The PDF
Brochure_at_ http//www.marketsandmarkets.com/pdfdown
load.asp?id73180930 Downstream Processing in
Biopharmaceuticals is poised to reach USD 22.03
Billion by 2021 from USD 10.32 Billion in 2016,
at a CAGR of 16.4 from 2016 to 2021.
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
3
The growth in the Downstream Bioprocessing
Market and Downstream Processing in
Biopharmaceuticals will majorly be driven by
the increasing demand for biopharmaceuticals, as
downstream processing steps play a significant
role in providing pure and quality products.
However, the high cost of instruments used in
downstream processing is expected to restrain the
growth of this market.   On the other hand,
patent expiration of blockbuster
biopharmaceutical products represents significant
growth opportunities for the key players in the
downstream processing market. Request Sample_at_
http//www.marketsandmarkets.com/requestsample.as
p?id73180930 the global market is broadly
segmented by technique, product, application, end
user, and region. On the basis of product, the
market is classified into chromatography columns
and resins, filters, membrane adsorbers,
single-use products, and other products.
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
4
Based on technique, the market is segmented into
purification, solid-liquid separation, and
clarification/concentration. In 2016, the
purification segment accounted for the largest
share of the market. Based on application, the
downstream processing market is categorized into
monoclonal antibody (mAbs) production, vaccine
production, insulin production, immunoglobulin
production, erythropoietin production, and other
applications. Based on end user, the market is
segmented into biopharmaceutical manufacturers
and contract manufacturing organizations (CMOs).
In 2016, the biopharmaceutical manufacturers
segment accounted for the largest share of the
market. Stakeholders Vendors/service
providers Research and consulting
firms Biopharmaceutical manufacturers Contract
manufacturing organizations (CMOs) Contract
research organizations (CROs)
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
5
North America is the worlds largest
pharmaceutical market and a leader in
biopharmaceutical research. North America
(comprising the U.S. and Canada) accounted for
the largest share of the global market in 2016.
Rising quality requirements have emphasized the
need for advanced bioproduction technology in
this region. The downstream processing market is
dominated by established players such as Thermo
Fisher Scientific Inc. (U.S.), GE Healthcare
(U.S.), Sartorius Stedim Biotech S.A. (France),
Merck Millipore (Germany), and Danaher
Corporation (U.S.).
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/do
wnstream-processing-market-73180930.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
8
(No Transcript)